image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 135.05
-5.05 %
$ 21.4 B
Market Cap
-13.55
P/E
1. INTRINSIC VALUE

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.[ Read More ]

The intrinsic value of one ILMN stock under the base case scenario is HIDDEN Compared to the current market price of 135 USD, Illumina, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ILMN

image
FINANCIALS
4.5 B REVENUE
-1.75%
-1.07 B OPERATING INCOME
74.42%
-1.16 B NET INCOME
73.64%
478 M OPERATING CASH FLOW
21.94%
-231 M INVESTING CASH FLOW
60.91%
-1.21 B FINANCING CASH FLOW
-121.00%
1.08 B REVENUE
-2.88%
741 M OPERATING INCOME
53.10%
704 M NET INCOME
135.41%
316 M OPERATING CASH FLOW
295.00%
-41 M INVESTING CASH FLOW
-0.00%
-332 M FINANCING CASH FLOW
-46.90%
Balance Sheet Decomposition Illumina, Inc.
image
Current Assets 2.61 B
Cash & Short-Term Investments 1.05 B
Receivables 752 M
Other Current Assets 803 M
Non-Current Assets 7.5 B
Long-Term Investments 196 M
PP&E 1.55 B
Other Non-Current Assets 5.76 B
Current Liabilities 1.57 B
Accounts Payable 245 M
Short-Term Debt 86 M
Other Current Liabilities 1.24 B
Non-Current Liabilities 2.8 B
Long-Term Debt 2.18 B
Other Non-Current Liabilities 620 M
EFFICIENCY
Earnings Waterfall Illumina, Inc.
image
Revenue 4.5 B
Cost Of Revenue 1.76 B
Gross Profit 2.74 B
Operating Expenses 3.81 B
Operating Income -1.07 B
Other Expenses 92 M
Net Income -1.16 B
RATIOS
60.92% GROSS MARGIN
60.92%
-23.73% OPERATING MARGIN
-23.73%
-25.78% NET MARGIN
-25.78%
-20.21% ROE
-20.21%
-11.48% ROA
-11.48%
-15.36% ROIC
-15.36%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Illumina, Inc.
image
Net Income -1.16 B
Depreciation & Amortization 432 M
Capital Expenditures -195 M
Stock-Based Compensation 380 M
Change in Working Capital -90 M
Others 964 M
Free Cash Flow 282 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Illumina, Inc.
image
Wall Street analysts predict an average 1-year price target for ILMN of $150 , with forecasts ranging from a low of $58 to a high of $200 .
ILMN Lowest Price Target Wall Street Target
58 USD -57.05%
ILMN Average Price Target Wall Street Target
150 USD 10.78%
ILMN Highest Price Target Wall Street Target
200 USD 48.09%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Illumina, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
992 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
8 months ago
Feb 22, 2024
Bought 94.9 K USD
Thaysen Jacob
Chief Executive Officer
+ 692
137.18 USD
8 months ago
Feb 22, 2024
Bought 211 K USD
Thaysen Jacob
Chief Executive Officer
+ 1553
135.69 USD
8 months ago
Feb 22, 2024
Bought 686 K USD
Thaysen Jacob
Chief Executive Officer
+ 5085
134.91 USD
1 year ago
Nov 07, 2023
Sell 35.5 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 315
112.84 USD
1 year ago
Aug 22, 2023
Sell 83.5 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 500
167.04 USD
1 year ago
Jul 24, 2023
Sell 95 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 500
190.08 USD
1 year ago
Jun 22, 2023
Sell 100 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 500
200 USD
1 year ago
May 22, 2023
Sell 41.1 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 200
205.63 USD
1 year ago
May 22, 2023
Sell 336 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 1618
207.75 USD
1 year ago
May 22, 2023
Sell 314 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 1506
208.7 USD
1 year ago
May 22, 2023
Sell 351 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 1676
209.67 USD
1 year ago
Mar 01, 2023
Sell 780 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 3917
199.0649 USD
1 year ago
Feb 22, 2023
Sell 620 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 3078
201.42 USD
1 year ago
Feb 22, 2023
Sell 469 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 2320
202.16 USD
1 year ago
Feb 06, 2023
Sell 106 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 500
211.57 USD
1 year ago
Jan 09, 2023
Sell 179 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 871
205.57 USD
1 year ago
Jan 06, 2023
Sell 102 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 500
204.58 USD
1 year ago
Dec 06, 2022
Sell 106 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 500
212.63 USD
2 years ago
Nov 07, 2022
Sell 234 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 1045
223.65 USD
2 years ago
Nov 07, 2022
Sell 112 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 500
223.65 USD
2 years ago
Nov 07, 2022
Sell 289 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 1294
223.65 USD
2 years ago
Nov 08, 2022
Sell 78.7 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 361
218 USD
2 years ago
Oct 06, 2022
Sell 108 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 500
216.59 USD
2 years ago
Jul 05, 2022
Sell 108 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 539
200 USD
2 years ago
Jun 10, 2022
Sell 53.7 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 250
214.85 USD
2 years ago
Apr 28, 2022
Sell 110 K USD
Dadswell Charles
SVP & General Counsel
- 368
300.13 USD
2 years ago
Apr 12, 2022
Sell 68.2 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 200
341.13 USD
2 years ago
Apr 12, 2022
Sell 34.3 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 100
342.98 USD
2 years ago
Apr 12, 2022
Sell 41.7 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 121
344.78 USD
2 years ago
Apr 12, 2022
Sell 34.6 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 100
346.25 USD
2 years ago
Apr 12, 2022
Sell 105 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 300
349.46 USD
2 years ago
Apr 12, 2022
Sell 548 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 1553
352.82 USD
2 years ago
Apr 12, 2022
Sell 35.5 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 100
355.38 USD
2 years ago
Apr 05, 2022
Sell 716 K USD
Febbo Phillip G.
SVP Chief Medical Officer
- 1988
360.01 USD
2 years ago
Mar 28, 2022
Sell 126 K USD
Dadswell Charles
SVP & General Counsel
- 368
342.83 USD
2 years ago
Jan 12, 2022
Sell 340 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 800
425 USD
2 years ago
Dec 28, 2021
Sell 38.7 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 100
387.06 USD
2 years ago
Dec 22, 2021
Sell 122 K USD
Dadswell Charles
SVP & General Counsel
- 322
380.29 USD
2 years ago
Dec 08, 2021
Sell 37.5 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 100
375 USD
2 years ago
Dec 08, 2021
Sell 37.5 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 100
375 USD
2 years ago
Nov 22, 2021
Sell 119 K USD
Dadswell Charles
SVP, General Counsel
- 314
377.86 USD
3 years ago
Nov 12, 2021
Sell 139 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 361
386.35 USD
3 years ago
Nov 08, 2021
Sell 407 K USD
Febbo Phillip G.
SVP Chief Medical Officer
- 1000
406.83 USD
3 years ago
Nov 08, 2021
Sell 407 K USD
Febbo Phillip G.
SVP Chief Medical Officer
- 1000
406.83 USD
3 years ago
Nov 02, 2021
Sell 81.9 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 200
409.28 USD
3 years ago
Nov 02, 2021
Sell 262 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 639
410.47 USD
3 years ago
Nov 02, 2021
Sell 265 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 645
411.47 USD
3 years ago
Nov 02, 2021
Sell 151 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 366
412.15 USD
3 years ago
Nov 02, 2021
Sell 162 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 393
413.24 USD
3 years ago
Nov 02, 2021
Sell 83.3 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 200
416.48 USD
3 years ago
Nov 02, 2021
Sell 202 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 483
417.62 USD
3 years ago
Oct 28, 2021
Sell 41.4 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 100
414.35 USD
3 years ago
Oct 26, 2021
Sell 1.24 M USD
Aravanis Alexander
SVP, Chief Technology Officer
- 2926
423 USD
3 years ago
Oct 22, 2021
Sell 129 K USD
Dadswell Charles
SVP & General Counsel
- 314
411 USD
3 years ago
Oct 19, 2021
Sell 246 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 600
410.42 USD
3 years ago
Oct 19, 2021
Sell 390 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 948
411.38 USD
3 years ago
Oct 19, 2021
Sell 433 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 1051
412.28 USD
3 years ago
Oct 19, 2021
Sell 63.7 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 154
413.52 USD
3 years ago
Oct 19, 2021
Sell 71.7 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 173
414.7 USD
3 years ago
Oct 12, 2021
Sell 172 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 423
407.29 USD
3 years ago
Oct 12, 2021
Sell 306 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 750
408.33 USD
3 years ago
Oct 12, 2021
Sell 366 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 893
409.48 USD
3 years ago
Oct 12, 2021
Sell 291 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 709
410.52 USD
3 years ago
Oct 12, 2021
Sell 62.1 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 151
411.22 USD
3 years ago
Sep 28, 2021
Sell 41.8 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 100
418.04 USD
3 years ago
Sep 22, 2021
Sell 137 K USD
Dadswell Charles
SVP & General Counsel
- 314
436.69 USD
3 years ago
Apr 05, 2021
Sell 386 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 1000
386.03 USD
3 years ago
Apr 06, 2021
Sell 212 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 500
425 USD
3 years ago
Apr 06, 2021
Sell 212 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 500
423.435 USD
3 years ago
Jun 10, 2021
Sell 225 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 500
450 USD
3 years ago
Jun 24, 2021
Sell 238 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 500
475 USD
3 years ago
Aug 04, 2021
Sell 186 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 372
500 USD
3 years ago
Aug 30, 2021
Sell 139 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 300
463.5 USD
3 years ago
Aug 23, 2021
Sell 154 K USD
Dadswell Charles
SVP & General Counsel
- 314
489.1 USD
3 years ago
Aug 04, 2021
Sell 500 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 1000
500 USD
3 years ago
Jul 28, 2021
Sell 146 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 300
486.41 USD
3 years ago
Jul 22, 2021
Sell 151 K USD
Dadswell Charles
SVP & General Counsel
- 314
482.23 USD
3 years ago
Jul 07, 2021
Sell 257 K USD
Aravanis Alexander
SVP, Chief Technology Officer
- 539
477.59 USD
3 years ago
Jun 28, 2021
Sell 144 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 300
478.95 USD
3 years ago
Jun 22, 2021
Sell 145 K USD
Dadswell Charles
SVP & General Counsel
- 314
461.01 USD
3 years ago
Jun 11, 2021
Sell 138 K USD
Febbo Phillip G.
SVP Chief Medical Officer
- 310
446.17 USD
3 years ago
Jun 11, 2021
Sell 179 K USD
Febbo Phillip G.
SVP Chief Medical Officer
- 400
447.65 USD
3 years ago
Jun 11, 2021
Sell 130 K USD
Febbo Phillip G.
SVP Chief Medical Officer
- 290
449.02 USD
3 years ago
Jun 10, 2021
Sell 450 K USD
DORSA CAROLINE
Director
- 1000
450 USD
3 years ago
May 24, 2021
Sell 127 K USD
Dadswell Charles
SVP & General Counsel
- 314
403.04 USD
3 years ago
May 20, 2021
Sell 200 K USD
TOUSI SUSAN H
SVP, Chief Commercial Officer
- 500
400 USD
3 years ago
May 18, 2021
Sell 1.52 M USD
FLATLEY JAY T
Director
- 4000
379.53 USD
3 years ago
May 05, 2021
Sell 115 K USD
TOUSI SUSAN H
SVP Product Development
- 300
381.88 USD
3 years ago
May 04, 2021
Sell 1.54 M USD
FLATLEY JAY T
Director
- 4000
384.15 USD
3 years ago
Apr 22, 2021
Sell 126 K USD
Dadswell Charles
SVP & General Counsel
- 314
402.02 USD
3 years ago
Apr 20, 2021
Sell 1.61 M USD
FLATLEY JAY T
Director
- 4000
401.83 USD
3 years ago
Apr 06, 2021
Sell 1.69 M USD
FLATLEY JAY T
Director
- 4000
423.435 USD
3 years ago
Apr 05, 2021
Sell 116 K USD
TOUSI SUSAN H
SVP Product Development
- 300
386.03 USD
3 years ago
Apr 05, 2021
Sell 116 K USD
TOUSI SUSAN H
SVP Product Development
- 300
386.03 USD
3 years ago
Apr 06, 2021
Sell 212 K USD
TOUSI SUSAN H
SVP Product Development
- 500
423.435 USD
3 years ago
Apr 06, 2021
Sell 212 K USD
TOUSI SUSAN H
SVP Product Development
- 500
423.435 USD
3 years ago
Mar 22, 2021
Sell 131 K USD
Dadswell Charles
SVP & General Counsel
- 314
416.24 USD
3 years ago
Mar 16, 2021
Sell 1.68 M USD
FLATLEY JAY T
Director
- 4000
421.06 USD
3 years ago
Mar 05, 2021
Sell 322 K USD
TOUSI SUSAN H
SVP Product Development
- 800
402.24 USD
3 years ago
Mar 02, 2021
Sell 1.78 M USD
FLATLEY JAY T
Director
- 4000
444.61 USD
3 years ago
Feb 18, 2021
Sell 324 K USD
MCGINNIS KAREN K
VP, Chief Accounting Officer
- 666
486.75 USD
3 years ago
Feb 16, 2021
Sell 2.02 M USD
FLATLEY JAY T
Director
- 4000
505.26 USD
3 years ago
Feb 16, 2021
Sell 124 K USD
FLATLEY JAY T
Director
- 250
495.5052 USD
3 years ago
Feb 16, 2021
Sell 124 K USD
FLATLEY JAY T
Director
- 250
494.665 USD
3 years ago
Feb 05, 2021
Sell 346 K USD
TOUSI SUSAN H
SVP Product Development
- 800
431.9 USD
3 years ago
Feb 02, 2021
Sell 25.4 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 57
444.84 USD
3 years ago
Feb 02, 2021
Sell 1.78 M USD
FLATLEY JAY T
Director
- 4000
444.84 USD
3 years ago
Feb 02, 2021
Sell 32 K USD
MCGINNIS KAREN K
VP, Chief Accounting Officer
- 72
444.84 USD
3 years ago
Feb 01, 2021
Sell 76.8 K USD
deSouza Francis A
President and CEO
- 178
431.5 USD
3 years ago
Feb 01, 2021
Sell 39.5 K USD
deSouza Francis A
President and CEO
- 91
433.98 USD
3 years ago
Feb 01, 2021
Sell 133 K USD
deSouza Francis A
President and CEO
- 306
435.52 USD
3 years ago
Feb 01, 2021
Sell 75.9 K USD
deSouza Francis A
President and CEO
- 174
436.47 USD
3 years ago
Feb 01, 2021
Sell 56 K USD
deSouza Francis A
President and CEO
- 128
437.66 USD
3 years ago
Feb 01, 2021
Sell 142 K USD
deSouza Francis A
President and CEO
- 323
439.1 USD
3 years ago
Feb 01, 2021
Sell 197 K USD
deSouza Francis A
President and CEO
- 447
440.63 USD
3 years ago
Feb 01, 2021
Sell 310 K USD
deSouza Francis A
President and CEO
- 701
441.71 USD
3 years ago
Feb 01, 2021
Sell 108 K USD
deSouza Francis A
President and CEO
- 245
442.74 USD
3 years ago
Feb 01, 2021
Sell 86.1 K USD
deSouza Francis A
President and CEO
- 194
443.71 USD
3 years ago
Feb 01, 2021
Sell 56.9 K USD
deSouza Francis A
President and CEO
- 128
444.81 USD
3 years ago
Feb 01, 2021
Sell 37.9 K USD
deSouza Francis A
President and CEO
- 85
445.64 USD
3 years ago
Jan 20, 2021
Sell 1 M USD
TOUSI SUSAN H
SVP Product Development
- 2500
400 USD
3 years ago
Jan 19, 2021
Sell 1.53 M USD
FLATLEY JAY T
Director
- 4000
382.48 USD
3 years ago
Jan 11, 2021
Sell 103 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 271
379.65 USD
3 years ago
Jan 05, 2021
Sell 110 K USD
TOUSI SUSAN H
SVP Product Development
- 300
365.27 USD
3 years ago
Jan 05, 2021
Sell 1.46 M USD
FLATLEY JAY T
Director
- 4000
365.27 USD
3 years ago
Jan 04, 2021
Sell 135 K USD
deSouza Francis A
President and CEO
- 369
366.84 USD
3 years ago
Jan 04, 2021
Sell 87.5 K USD
deSouza Francis A
President and CEO
- 238
367.75 USD
3 years ago
Jan 04, 2021
Sell 61.6 K USD
deSouza Francis A
President and CEO
- 167
368.84 USD
3 years ago
Jan 04, 2021
Sell 154 K USD
deSouza Francis A
President and CEO
- 416
370.29 USD
3 years ago
Jan 04, 2021
Sell 342 K USD
deSouza Francis A
President and CEO
- 921
371.18 USD
3 years ago
Jan 04, 2021
Sell 217 K USD
deSouza Francis A
President and CEO
- 582
372.07 USD
3 years ago
Jan 04, 2021
Sell 87.3 K USD
deSouza Francis A
President and CEO
- 234
373.11 USD
3 years ago
Jan 04, 2021
Sell 27.3 K USD
deSouza Francis A
President and CEO
- 73
374.01 USD
3 years ago
Dec 15, 2020
Sell 1.4 M USD
FLATLEY JAY T
Director
- 4000
348.84 USD
3 years ago
Dec 14, 2020
Sell 122 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 354
345 USD
3 years ago
Dec 10, 2020
Sell 438 K USD
Ronaghi Mostafa
SVP, Entrepreneurial Devlopmt
- 1300
336.9247 USD
3 years ago
Dec 10, 2020
Sell 372 K USD
Ronaghi Mostafa
SVP, Entrepreneurial Devlopmt
- 1100
337.9917 USD
3 years ago
Dec 10, 2020
Sell 747 K USD
Ronaghi Mostafa
SVP, Entrepreneurial Devlopmt
- 2200
339.4223 USD
3 years ago
Dec 10, 2020
Sell 136 K USD
Ronaghi Mostafa
SVP, Entrepreneurial Devlopmt
- 400
341 USD
3 years ago
Dec 04, 2020
Sell 70 K USD
TOUSI SUSAN H
SVP Product Development
- 200
350 USD
3 years ago
Dec 04, 2020
Sell 70 K USD
TOUSI SUSAN H
SVP Product Development
- 200
350 USD
3 years ago
Dec 07, 2020
Sell 34.8 K USD
TOUSI SUSAN H
SVP Product Development
- 100
348.03 USD
3 years ago
Dec 07, 2020
Sell 34.8 K USD
TOUSI SUSAN H
SVP Product Development
- 100
348.03 USD
3 years ago
Dec 07, 2020
Sell 70 K USD
TOUSI SUSAN H
SVP Product Development
- 200
350 USD
3 years ago
Dec 07, 2020
Sell 70 K USD
TOUSI SUSAN H
SVP Product Development
- 200
350 USD
3 years ago
Dec 01, 2020
Sell 549 K USD
Dadswell Charles
SVP & General Counsel
- 1694
323.86 USD
3 years ago
Dec 01, 2020
Sell 182 K USD
deSouza Francis A
President and CEO
- 561
323.83 USD
3 years ago
Dec 01, 2020
Sell 46.1 K USD
deSouza Francis A
President and CEO
- 142
324.61 USD
3 years ago
Dec 01, 2020
Sell 73.3 K USD
deSouza Francis A
President and CEO
- 225
325.79 USD
3 years ago
Dec 01, 2020
Sell 62.1 K USD
deSouza Francis A
President and CEO
- 190
326.76 USD
3 years ago
Dec 01, 2020
Sell 114 K USD
deSouza Francis A
President and CEO
- 348
327.97 USD
3 years ago
Dec 01, 2020
Sell 280 K USD
deSouza Francis A
President and CEO
- 851
329.02 USD
3 years ago
Dec 01, 2020
Sell 71.9 K USD
deSouza Francis A
President and CEO
- 218
329.73 USD
3 years ago
Dec 01, 2020
Sell 17.2 K USD
deSouza Francis A
President and CEO
- 52
331.01 USD
3 years ago
Dec 01, 2020
Sell 120 K USD
deSouza Francis A
President and CEO
- 361
332.78 USD
3 years ago
Dec 01, 2020
Sell 17.3 K USD
deSouza Francis A
President and CEO
- 52
333.53 USD
3 years ago
Dec 01, 2020
Sell 32.5 K USD
TOUSI SUSAN H
SVP Product Development
- 100
325 USD
3 years ago
Dec 01, 2020
Sell 972 K USD
FLATLEY JAY T
Director
- 3000
323.86 USD
3 years ago
Dec 01, 2020
Sell 324 K USD
FLATLEY JAY T
Director
- 1000
324.01 USD
3 years ago
Nov 30, 2020
Sell 56 K USD
RAGUSA ROBERT P
SVP, Global Quality & Ops
- 180
311.34 USD
3 years ago
Nov 30, 2020
Sell 289 K USD
RAGUSA ROBERT P
SVP, Global Quality & Ops
- 926
312.35 USD
3 years ago
Nov 30, 2020
Sell 15.7 K USD
RAGUSA ROBERT P
SVP, Global Quality & Ops
- 50
313.13 USD
3 years ago
Nov 30, 2020
Sell 183 K USD
RAGUSA ROBERT P
SVP, Global Quality & Ops
- 580
314.74 USD
3 years ago
Nov 30, 2020
Sell 47.4 K USD
RAGUSA ROBERT P
SVP, Global Quality & Ops
- 150
315.76 USD
3 years ago
Nov 30, 2020
Sell 265 K USD
RAGUSA ROBERT P
SVP, Global Quality & Ops
- 834
317.44 USD
3 years ago
Nov 30, 2020
Sell 38.3 K USD
RAGUSA ROBERT P
SVP, Global Quality & Ops
- 120
318.83 USD
3 years ago
Nov 30, 2020
Sell 16 K USD
RAGUSA ROBERT P
SVP, Global Quality & Ops
- 50
319.5 USD
4 years ago
Nov 17, 2020
Sell 593 K USD
FLATLEY JAY T
Director
- 2000
296.73 USD
4 years ago
Nov 17, 2020
Sell 298 K USD
FLATLEY JAY T
Director
- 1000
298.01 USD
4 years ago
Nov 18, 2020
Sell 65.4 K USD
MCGINNIS KAREN K
VP, Chief Accounting Officer
- 218
300 USD
4 years ago
Nov 06, 2020
Sell 96.8 K USD
MCGINNIS KAREN K
VP, Chief Accounting Officer
- 312
310.1 USD
4 years ago
Nov 06, 2020
Sell 66.7 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 215
310.1 USD
4 years ago
Nov 06, 2020
Sell 48.1 K USD
Febbo Phillip G.
SVP Chief Medical Officer
- 155
310.1 USD
4 years ago
Nov 03, 2020
Sell 594 K USD
FLATLEY JAY T
Director
- 2000
297 USD
4 years ago
Nov 03, 2020
Sell 298 K USD
FLATLEY JAY T
Director
- 1000
298.01 USD
4 years ago
Nov 02, 2020
Sell 84.2 K USD
deSouza Francis A
President and CEO
- 283
297.4 USD
4 years ago
Nov 02, 2020
Sell 169 K USD
deSouza Francis A
President and CEO
- 566
298.44 USD
4 years ago
Nov 02, 2020
Sell 175 K USD
deSouza Francis A
President and CEO
- 585
299.55 USD
4 years ago
Nov 02, 2020
Sell 140 K USD
deSouza Francis A
President and CEO
- 465
300.56 USD
4 years ago
Nov 02, 2020
Sell 144 K USD
deSouza Francis A
President and CEO
- 477
301.68 USD
4 years ago
Nov 02, 2020
Sell 189 K USD
deSouza Francis A
President and CEO
- 624
302.68 USD
4 years ago
Nov 02, 2020
Sell 36.1 K USD
Dadswell Charles
SVP & General Counsel
- 121
298 USD
4 years ago
Oct 20, 2020
Sell 963 K USD
FLATLEY JAY T
Director
- 3000
320.95 USD
4 years ago
Oct 20, 2020
Sell 324 K USD
FLATLEY JAY T
Director
- 1000
324.01 USD
4 years ago
Oct 12, 2020
Sell 70 K USD
TOUSI SUSAN H
SVP Product Development
- 200
350 USD
4 years ago
Oct 07, 2020
Sell 32.5 K USD
TOUSI SUSAN H
SVP Product Development
- 100
325 USD
4 years ago
Oct 07, 2020
Sell 324 K USD
FLATLEY JAY T
Director
- 1000
324.01 USD
4 years ago
Oct 06, 2020
Sell 953 K USD
FLATLEY JAY T
Director
- 3000
317.79 USD
4 years ago
Oct 01, 2020
Sell 241 K USD
deSouza Francis A
President and CEO
- 785
306.99 USD
4 years ago
Oct 01, 2020
Sell 172 K USD
deSouza Francis A
President and CEO
- 559
307.78 USD
4 years ago
Oct 01, 2020
Sell 184 K USD
deSouza Francis A
President and CEO
- 595
308.84 USD
4 years ago
Oct 01, 2020
Sell 188 K USD
deSouza Francis A
President and CEO
- 608
309.89 USD
4 years ago
Oct 01, 2020
Sell 37.6 K USD
deSouza Francis A
President and CEO
- 121
310.55 USD
4 years ago
Oct 01, 2020
Sell 88.2 K USD
deSouza Francis A
President and CEO
- 283
311.72 USD
4 years ago
Oct 01, 2020
Sell 15.3 K USD
deSouza Francis A
President and CEO
- 49
312.82 USD
4 years ago
Oct 01, 2020
Sell 37.9 K USD
Dadswell Charles
SVP & General Counsel
- 121
312.82 USD
4 years ago
Sep 15, 2020
Sell 1.42 M USD
FLATLEY JAY T
Director
- 4000
355.22 USD
4 years ago
Sep 08, 2020
Sell 33.6 K USD
TOUSI SUSAN H
SVP Product Development
- 100
336 USD
4 years ago
Sep 09, 2020
Sell 70 K USD
TOUSI SUSAN H
SVP Product Development
- 200
350 USD
4 years ago
Sep 01, 2020
Sell 208 K USD
Van Oene Mark
SVP Chief Commercial Officer
- 585
355.0389 USD
4 years ago
Sep 01, 2020
Sell 14.3 K USD
Van Oene Mark
SVP Chief Commercial Officer
- 40
356.385 USD
4 years ago
Sep 01, 2020
Sell 140 K USD
deSouza Francis A
President and CEO
- 400
349.5525 USD
4 years ago
Sep 01, 2020
Sell 319 K USD
deSouza Francis A
President and CEO
- 909
350.7324 USD
4 years ago
Sep 01, 2020
Sell 176 K USD
deSouza Francis A
President and CEO
- 500
351.759 USD
4 years ago
Sep 01, 2020
Sell 106 K USD
deSouza Francis A
President and CEO
- 300
353.0067 USD
4 years ago
Sep 01, 2020
Sell 106 K USD
deSouza Francis A
President and CEO
- 300
354.1667 USD
4 years ago
Sep 01, 2020
Sell 210 K USD
deSouza Francis A
President and CEO
- 591
355.8305 USD
4 years ago
Sep 01, 2020
Sell 599 K USD
Dadswell Charles
SVP & General Counsel
- 1687
355.35 USD
4 years ago
Sep 01, 2020
Sell 1.42 M USD
FLATLEY JAY T
Director
- 4000
355.35 USD
4 years ago
Aug 31, 2020
Sell 199 K USD
RAGUSA ROBERT P
SVP, Global Quality & Ops
- 565
352.9273 USD
4 years ago
Aug 31, 2020
Sell 389 K USD
RAGUSA ROBERT P
SVP, Global Quality & Ops
- 1100
354.0886 USD
4 years ago
Aug 31, 2020
Sell 658 K USD
RAGUSA ROBERT P
SVP, Global Quality & Ops
- 1852
355.3051 USD
4 years ago
Aug 31, 2020
Sell 303 K USD
RAGUSA ROBERT P
SVP, Global Quality & Ops
- 850
355.9974 USD
4 years ago
Aug 31, 2020
Sell 226 K USD
RAGUSA ROBERT P
SVP, Global Quality & Ops
- 633
357.6341 USD
4 years ago
Aug 18, 2020
Sell 1.42 M USD
FLATLEY JAY T
Director
- 4000
354.03 USD
4 years ago
Aug 10, 2020
Sell 663 K USD
MCGINNIS KAREN K
VP, Chief Accounting Officer
- 1856
357.01 USD
4 years ago
Aug 05, 2020
Sell 119 K USD
TOUSI SUSAN H
SVP Product Development
- 300
397.4 USD
4 years ago
Aug 05, 2020
Sell 200 K USD
TOUSI SUSAN H
SVP Product Development
- 500
400 USD
4 years ago
Aug 04, 2020
Sell 11.5 K USD
Hoyt Aimee L
SVP, Chief People Officer
- 29
397.73 USD
4 years ago
Aug 04, 2020
Sell 1.59 M USD
FLATLEY JAY T
Director
- 4000
397.73 USD
4 years ago
Aug 03, 2020
Sell 241 K USD
Van Oene Mark
SVP Chief Commercial Officer
- 625
385.43 USD
4 years ago
Aug 03, 2020
Sell 46.6 K USD
Dadswell Charles
SVP & General Counsel
- 121
385.19 USD
4 years ago
Aug 03, 2020
Sell 81.7 K USD
deSouza Francis A
President and CEO
- 212
385.59 USD
4 years ago
Aug 03, 2020
Sell 193 K USD
deSouza Francis A
President and CEO
- 500
386.79 USD
4 years ago
Aug 03, 2020
Sell 77.6 K USD
deSouza Francis A
President and CEO
- 200
388.14 USD
4 years ago
Aug 03, 2020
Sell 195 K USD
deSouza Francis A
President and CEO
- 500
389.09 USD
4 years ago
Aug 03, 2020
Sell 195 K USD
deSouza Francis A
President and CEO
- 500
390.49 USD
4 years ago
Aug 03, 2020
Sell 157 K USD
deSouza Francis A
President and CEO
- 400
391.46 USD
4 years ago
Aug 03, 2020
Sell 192 K USD
deSouza Francis A
President and CEO
- 488
392.87 USD
4 years ago
Aug 03, 2020
Sell 78.7 K USD
deSouza Francis A
President and CEO
- 200
393.4 USD
4 years ago
Jul 20, 2020
Sell 200 K USD
TOUSI SUSAN H
SVP Product Development
- 500
400 USD
4 years ago
Jul 21, 2020
Sell 1.6 M USD
FLATLEY JAY T
Director
- 4000
399 USD
4 years ago
Jul 07, 2020
Sell 1.48 M USD
FLATLEY JAY T
Director
- 4000
370.22 USD
4 years ago
Jul 06, 2020
Sell 112 K USD
TOUSI SUSAN H
SVP Product Development
- 300
375 USD
7. News
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 5 days ago
Interpreting Illumina (ILMN) International Revenue Trends Explore how Illumina's (ILMN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects. zacks.com - 1 week ago
Illumina To Webcast Upcoming Investor Conferences SAN DIEGO , Nov. 6, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences: Wolfe Research 2024 Healthcare Conference on November 20, 2024 Fireside chat at 6:20am Pacific Time (9:20am Eastern Time) 7th Annual Evercore HealthCONx Conference on December 3, 2024 Fireside chat at 10:20am Pacific Time (1:20pm Eastern Time) For each conference, the webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after each event and will be available for at least 30 days following. prnewswire.com - 1 week ago
Illumina: Q3 Confirms Improving Fundamentals Illumina is the leader in the undisputed Next Generation Sequencing market. Grail divestment is behind, enabling a margin expansion and fueling a more robust cash flow generation. The stock was down after hours, as much good news has been priced in the recent rally. seekingalpha.com - 1 week ago
ILMN Q3 Earnings Top, '24 Sales View Down, Stock Dips in Aftermarket Illumina's third- quarter revenues from the consumables business show robust growth, offset by the declining instruments business. zacks.com - 1 week ago
Illumina (ILMN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com - 1 week ago
Illumina, Inc. (ILMN) Q3 2024 Earnings Call Transcript Illumina, Inc. (NASDAQ:ILMN ) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Corporate Participants Salli Schwartz - Vice President of Investor Relations Jacob Thaysen - Chief Executive Officer Ankur Dhingra - Chief Financial Officer Conference Call Participants Doug Schenkel - Wolfe Research Puneet Souda - Leerink Partners Vijay Kumar - Evercore ISI Dan Brennan - TD Cowen Tycho Peterson - Jefferies David Westenberg - Piper Sandler Conor McNamara - RBC Capital Markets Dan Arias - Stifel Patrick Donnelly - Citi Subha Nambi - Guggenheim Sung Ji Nam - Scotiabank Ben Mee - Stephens Dan Leonard - UBS Operator Good day, ladies and gentlemen, and welcome to the Third Quarter 2024 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com - 1 week ago
Illumina (ILMN) Tops Q3 Earnings and Revenue Estimates Illumina (ILMN) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $0.33 per share a year ago. zacks.com - 1 week ago
EARNINGS ALERT: ILMN Illumina (ILMN) is trading down guiding a 3% decline in revenue. George Tsilis believes the company is still notable despite the market's reaction. youtube.com - 1 week ago
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024 Core Illumina revenue of $1.1 billion for Q3 2024, down 2% from Q3 2023 and on a constant currency basis Core Illumina GAAP operating margin of 68.6% and non-GAAP operating margin of 22.6% for Q3 2024 Core Illumina GAAP diluted EPS of $4.03 and non-GAAP diluted EPS of $1.14 for Q3 2024 Lowered fiscal year 2024 Core Illumina revenue guidance to decline ~3% from fiscal year 2023; expect Q4 2024 Core Illumina revenue of approximately $1.07 billion Raised fiscal year 2024 Core Illumina non-GAAP operating margin guidance to a range of 21% to 21.5% Raised fiscal year 2024 Core Illumina non-GAAP diluted EPS guidance to a range of $4.05 to $4.15 SAN DIEGO , Nov. 4, 2024 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the third quarter of fiscal year 2024. The financial results for YTD 2024 and Q3 2023 and YTD 2023 include the financial results for GRAIL which was spun off on June 24, 2024. prnewswire.com - 1 week ago
Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual Meeting New, groundbreaking technology delivers Illumina's most comprehensive genome yet ; early results from Broad Clinical Labs demonstrate a highly simplified workflow , ultra-long phasing, high-resolution insights into complex genomic variation, and enhanced long-range information   Illumina and customers will also showcase new details on complete proteomics solution and latest data on Fluent single-cell technology SAN DIEGO , Oct. 31, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will present updates on several key innovations in whole-genome sequencing, proteomics, and single-cell technology at the American Society of Human Genetics (ASHG) Annual Meeting next week in Denver. The latest details will be presented alongside new data from key opinion leaders in next-generation sequencing (NGS), illustrating the potential impact of Illumina's emerging innovations. prnewswire.com - 2 weeks ago
What Analyst Projections for Key Metrics Reveal About Illumina (ILMN) Q3 Earnings Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Illumina (ILMN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024. zacks.com - 2 weeks ago
8. Profile Summary

Illumina, Inc. ILMN

image
COUNTRY US
INDUSTRY Medical - Diagnostics & Research
MARKET CAP $ 21.4 B
Dividend Yield 0.00%
Description Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
Contact 5200 Illumina Way, San Diego, CA, 92122 https://www.illumina.com
IPO Date July 28, 2000
Employees 10590
Officers Mr. Scott Davies Interim General Counsel & Secretary Mr. Jakob Wedel Chief Strategy & Corporate Development Officer and Chief Executive Officer Chief of Staff Mr. Charles E. Dadswell Esq. Advisor Dr. Steven Barnard Ph.D. Chief Technology Officer Mr. Scott Ericksen Vice President & Chief Accounting Officer Ms. Sallilyn Schwartz Vice President of Investor Relations Stephanie Campos President Mr. Jacob Thaysen Ph.D. Chief Executive Officer & Director Ms. Carissa L. Rollins Chief Information Officer Mr. Kevin Carl Pegels Chief of Global Operations